3BNC117 Monoclonal Antibody in HIV-infected Subjects During Treatment Interruption

Summary

This study evaluates the effects of two infusions of 3BNC117 in preventing or delaying rebound of viral load during a brief treatment interruption of standard ART and its safety during a brief analytical interruption of antiretroviral therapy.

Timeline

Start

2015-03-11

Primary completion

2017-03-25

Completion

2017-03-25

Drugs

Indications